Executive Compensation Schedule for Named Officers of Myriad Genetics, Inc.
This document outlines the base salaries and bonuses for the fiscal years 2006 and 2007 for key executives of Myriad Genetics, Inc. and its subsidiaries. It lists the compensation details for the President and CEO, the Presidents of Myriad Genetic Laboratories and Myriad Pharmaceuticals, the Chief Financial Officer, and the Chief Scientific Officer. The agreement specifies annual base salaries, bonuses, and notes that one officer is paid hourly, with actual compensation depending on hours worked.
EXHIBIT 10.1
COMPENSATION OF NAMED EXECUTIVE OFFICERS
| Name and Position | Fiscal 2006 Base Salary ($) | Fiscal 2007 Base Salary ($) | Fiscal 2006 Bonus ($) | |||
| Peter D. Meldrum President and Chief Executive Officer | 615,000 | 676,500 | 338,250 | |||
| Gregory C. Critchfield, M.D. President, Myriad Genetic Laboratories, Inc. | 424,000 | 465,000 | 200,000 | |||
| Adrian N. Hobden, Ph.D. President, Myriad Pharmaceuticals, Inc. | 424,000 | 465,000 | 200,000 | |||
| Jay M. Moyes Chief Financial Officer | 326,500 | 355,000 | 160,000 | |||
| Mark H. Skolnick, Ph.D. (1) Chief Scientific Officer | 445,000 | 480,600 | 130,000 |
| (1) | Dr. Skolnick is compensated on an hourly basis. Base salary information reflects an annualized salary based on 2080 hours worked in a fiscal year. Actual amounts paid to Dr. Skolnick may vary significantly depending on the actual number of hours worked. |
